Document and Entity Information
Document and Entity Information | Feb. 04, 2021 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001714899 |
Document Type | 8-K |
Document Period End Date | Feb. 4, 2021 |
Entity Registrant Name | Denali Therapeutics Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38311 |
Entity Tax Identification Number | 46-3872213 |
Entity Address, Address Line One | 161 Oyster Point Blvd. |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | (650) |
Local Phone Number | 866-8548 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.01 per share |
Trading Symbol | DNLI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |